Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Immunobiology|December 4, 2014
Eculizumab treatment during pregnancy does not affect the complement system activity of the newbornRandi Fykse Hallstensen, Grethe Bergseth, Stian Foss, et al.
Bioconjugate Chemistry|July 25, 2022
Generation of Multivalent Nanobody-Based Proteins with Improved Neutralization of Long α-Neurotoxins from Elapid SnakesJack Wade, Charlotte Rimbault, Hanif Ali, et al.
Communications Biology|April 22, 2020
An intact C-terminal end of albumin is required for its long half-life in humansJeannette Nilsen, Esben Trabjerg, Algirdas Grevys, et al.
Frontiers in Immunology|June 27, 2022
Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune DisordersE Sally Ward, Deborah Gelinas, Erwin Dreesen, et al.
Nature Communications|December 22, 2011
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potentialNigel M Stapleton, Jan Terje Andersen, Annette M Stemerding, et al.
Protein Engineering, Design & Selection : PEDS|November 24, 2012
A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearancePaul J Yazaki, Brian Lee, Divya Channappa, et al.
Molecular Immunology|January 26, 2018
Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transportNigel M Stapleton, Sylvia S Armstrong-Fisher, Jan Terje Andersen, et al.
Communications Biology|July 31, 2024
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developabilityHabib Bashour, Eva Smorodina, Matteo Pariset, et al.
The Journal of Biological Chemistry|March 22, 2014
Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) bindingJan Terje Andersen, Bjørn Dalhus, Dorthe Viuff, et al.
Nature Communications|September 29, 2025
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional propertiesKristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, et al.
Pageof 11